Wells Fargo Maintains Overweight on Humana, Lowers Price Target to $541
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter has maintained an 'Overweight' rating on Humana (NYSE:HUM) but lowered the price target from $610 to $541.
July 13, 2023 | 11:46 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Humana's price target has been lowered by Wells Fargo from $610 to $541, although the 'Overweight' rating is maintained.
The lowering of the price target by Wells Fargo could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Overweight' rating indicates that the analyst still believes in the company's potential, which could offset some of the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100